Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Kiran Musunuru, M.D., Ph.D.

Concepts

This page shows the publications Kiran Musunuru has written about Antigens, Neoplasm.
Connection Strength

0.401
  1. Musunuru K, Darnell RB. Determination and augmentation of RNA sequence specificity of the Nova K-homology domains. Nucleic Acids Res. 2004; 32(16):4852-61.
    View in: PubMed
    Score: 0.177
  2. Teplova M, Malinina L, Darnell JC, Song J, Lu M, Abagyan R, Musunuru K, Teplov A, Burley SK, Darnell RB, Patel DJ. Protein-RNA and protein-protein recognition by dual KH1/2 domains of the neuronal splicing factor Nova-1. Structure. 2011 Jul 13; 19(7):930-44.
    View in: PubMed
    Score: 0.071
  3. Musunuru K, Kesari S. Paraneoplastic opsoclonus-myoclonus ataxia associated with non-small-cell lung carcinoma. J Neurooncol. 2008 Nov; 90(2):213-6.
    View in: PubMed
    Score: 0.058
  4. Jensen KB, Musunuru K, Lewis HA, Burley SK, Darnell RB. The tetranucleotide UCAY directs the specific recognition of RNA by the Nova K-homology 3 domain. Proc Natl Acad Sci U S A. 2000 May 23; 97(11):5740-5.
    View in: PubMed
    Score: 0.033
  5. Lewis HA, Musunuru K, Jensen KB, Edo C, Chen H, Darnell RB, Burley SK. Sequence-specific RNA binding by a Nova KH domain: implications for paraneoplastic disease and the fragile X syndrome. Cell. 2000 Feb 04; 100(3):323-32.
    View in: PubMed
    Score: 0.032
  6. Lewis HA, Chen H, Edo C, Buckanovich RJ, Yang YY, Musunuru K, Zhong R, Darnell RB, Burley SK. Crystal structures of Nova-1 and Nova-2 K-homology RNA-binding domains. Structure. 1999 Feb 15; 7(2):191-203.
    View in: PubMed
    Score: 0.030
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.